secwatch.observer — SEC 8-K summary
======================================

Issuer:     Voyager Therapeutics, Inc. (VYGR)
CIK:        0001640266
Form:       8-K
Filed at:   2025-06-05T23:59:59+00:00
Accession:  0001104659-25-056835
Event type: other
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Voyager stockholders approve 2025 stock plans, elect directors at annual meeting
--------------------------------------------------------------------------------

- Approved 2025 Stock Incentive Plan: 28.6M for, 11.3M against, 8.5M broker non-votes.
- Approved Amended and Restated 2015 ESPP: 36.5M for, 3.3M against, 8.5M broker non-votes.
- Elected Class I directors Colón, Mackey, Pierce, Scangos; Scangos had 6.7M votes withheld.
- Ratified Ernst & Young as FY2025 auditor: 48.1M for, 0.25M against.
- Say-on-pay approved: 37.8M for, 2.0M against, 0.1M abstain.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1640266/000110465925056835/0001104659-25-056835-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1640266/000110465925056835/tm2517216d2_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-056835

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer